lancet-header

Preprints with The Lancet is part of SSRN´s First Look, a place where journals identify content of interest prior to publication. Authors have opted in at submission to The Lancet family of journals to post their preprints on Preprints with The Lancet. The usual SSRN checks and a Lancet-specific check for appropriateness and transparency have been applied. Preprints available here are not Lancet publications or necessarily under review with a Lancet journal. These preprints are early stage research papers that have not been peer-reviewed. The findings should not be used for clinical or public health decision making and should not be presented to a lay audience without highlighting that they are preliminary and have not been peer-reviewed. For more information on this collaboration, see the comments published in The Lancet about the trial period, and our decision to make this a permanent offering, or visit The Lancet´s FAQ page, and for any feedback please contact preprints@lancet.com.

Combining Influenza and COVID-19 Booster Vaccination Strategy: A Systematic Review and Meta-Analysis

52 Pages Posted: 15 Nov 2022

See all articles by Nikolaos Tzenios

Nikolaos Tzenios

Charisma University - Public Health and Medical Research

Mary E. TAZANIOS

Clinical Research, TRG GEN+

Mohamad Chahine

Kursk State University - Biological and Chemical Technology

More...

Abstract

In this systematic review and meta-analysis, a synthesis of the findings and summary of a total of 30 research articles based on the topic, ‘combining influenza and COVID-19 booster vaccination strategy’ was undertaken. The research articles were identified from three databases, namely, PubMed, Cochran Library, and Google Scholar, using specific keywords and inclusion criteria. However, peer-reviewed research articles not published in English were excluded from the systematic review and meta-analysis. The average risk ratio of the included articles was 0.78% based on a 95% CI. On the other hand, the heterogeneity between such studies was I2, = 3the 5% while statistical significance of their findings occurred at p < 0.05p-value average p value of the included research studies was p =,0.62 which implies that the null hypothesis was not rejected in almost all the studies. A synthesis of the chosen research articles revealed that when influenza and COVID-19 booster vaccines are combined, there is potential for an increase in the latter's uptake, mainly because many populations have already been accustomed to taking influenza vaccines annually. In this way, through such findings, medical health experts can make informed decisions to increase the population's willingness to receive the COVID-19 booster vaccines.

Funding Information: None.

Declaration of Interests: None.

Keywords: Influenza, COVID-19 Booster, combined Vaccination

Suggested Citation

Tzenios, Nikolaos and TAZANIOS, Mary E. and Chahine, Mohamad, Combining Influenza and COVID-19 Booster Vaccination Strategy: A Systematic Review and Meta-Analysis. Available at SSRN: https://ssrn.com/abstract=4276608 or http://dx.doi.org/10.2139/ssrn.4276608

Nikolaos Tzenios (Contact Author)

Charisma University - Public Health and Medical Research ( email )

Mary E. TAZANIOS

Clinical Research, TRG GEN+ ( email )

Mohamad Chahine

Kursk State University - Biological and Chemical Technology ( email )

Click here to go to TheLancet.com

Paper statistics

Downloads
100
Abstract Views
583
PlumX Metrics